LNTH

Lantheus Holdings Inc

100.87

Aug 25 • 3:59 PM ET +0.07 (0.07%)

100.87

Aftermarket • 4:20 PM ET 0.00 (0.00%)

Healthcare Drug Manufacturers - Specialty & Generic USA Mid NASD

Peers: ALKS NBIX ACAD BMRN INCY IONS BIIB RGEN ALNY VRTX

| Held by: AVUV IJH VTI IWM VB VBK VXF IWO MDY VTWO

Scroll to Statements

Index	RUT
Market Cap	6.58B
Enterprise Value	6.62B
Income	275.31M
Sales	1.56B
Book/sh	20.10
Cash/sh	9.09
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	1193
IPO	Jun 25, 2015

P/E	24.38
Forward P/E	15.90
PEG	1.98
P/S	4.23
P/B	5.02
P/C	11.10
P/FCF	16.98
EV/EBITDA	16.91
EV/Sales	4.25
Quick Ratio	2.89
Current Ratio	3.06
Debt/Eq	0.48
LT Debt/Eq	0.48
Option/Short	Yes / Yes

EPS (ttm)	4.14
EPS next Y	6.34
EPS next Q	1.26
EPS this Y	-11.68%
EPS next Y	18.12%
EPS next 5Y	8.05%
EPS past 3/5Y	104.81% -
Sales past 3/5Y	18.13% 35.35%
EPS Y/Y TTM	7.38%
Sales Y/Y TTM	2.35%
EPS Q/Q	-0.79%
Sales Q/Q	2.68%
Earnings	Aug 06 BMO
EPS/Sales Surpr.	18.90% 6.87%

Insider Own	3.41%
Insider Trans	0.00%
Inst Own	116.65%
Inst Trans	1.62%
ROA	12.15%
ROE	22.21%
ROIC	14.22%
Gross Margin	60.14%
Oper. Margin	19.45%
Profit Margin	17.69%
SMA20	0.16%
SMA50	-2.86%
SMA200	22.58%
Trades

Shs Outstand	65.27M
Shs Float	63.05M
Short Float	10.01%
Short Ratio	4.70
Short Interest	6.31M
52W High	111.86 -9.82%
52W Low	49.67 103.08%
Volatility	0.63% 1.25%
ATR (14)	1.55
RSI (14)	46.64
Beta	-0.03
Rel Volume	0.62
Avg Volume	1.34M
Volume	837,367

Perf Week	0.61%
Perf Month	-6.63%
Perf Quarter	0.81%
Perf Half Y	37.03%
Perf YTD	51.57%
Perf Year	79.61%
Perf 3Y	51.98%
Perf 5Y	301.23%
Perf 10Y	1223.75%
Recom	2.64
Target Price	106.30
Prev Close	100.80
Price	100.87
Change %	0.07%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-26	Upgrade	William Blair	Mkt Perform → Outperform
Dec-12-25	Upgrade	Truist	Hold → Buy	$80
Oct-08-25	Downgrade	Goldman	Buy → Neutral	$77
Aug-12-25	Downgrade	Truist	Buy → Hold	$63
Dec-18-24	Initiated	Goldman	Buy	$143
Sep-03-24	Initiated	Redburn Atlantic	Buy	$175
Jul-10-24	Reiterated	JMP Securities	Mkt Outperform	$100 → $130
Dec-18-23	Downgrade	William Blair	Outperform → Mkt Perform
Dec-04-23	Initiated	TD Cowen	Outperform	$100
Sep-29-23	Initiated	William Blair	Outperform
Mar-08-23	Initiated	JMP Securities	Mkt Outperform	$120
Nov-30-22	Initiated	SVB Leerink	Outperform
Oct-13-22	Initiated	Mizuho	Buy	$105
May-09-22	Initiated	B. Riley Securities	Buy	$91
Apr-13-22	Initiated	Truist	Buy	$77
Feb-01-21	Initiated	SVB Leerink	Outperform	$24
Jun-29-20	Resumed	Jefferies	Buy	$29
Aug-16-19	Upgrade	CJS Securities	Market Perform → Market Outperform
Nov-02-17	Upgrade	Wells Fargo	Market Perform → Outperform
Nov-08-16	Reiterated	RBC Capital Mkts	Outperform	$6 → $12

Show Previous Ratings

Aug-14-26 08:00AM	Lantheus Announces FDA Approval of TAUKLARIFY (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer's Disease (GlobeNewswire)
Aug-07-26 02:16PM	Are DSGR, LNTH, ATKR Obtaining Fair Deals for their Shareholders? (PR Newswire)
Aug-06-26 07:33AM	Lantheus Holdings: Q2 Earnings Snapshot (Associated Press)
07:00AM	Lantheus Reports Second Quarter 2026 Financial Results (GlobeNewswire)
Aug-03-26 05:26PM	MRNA, LNTH, BMY, CAPR, RARE Stocks In Focus These FDA Decisions Could Shape August Trading (Stocktwits)
01:41PM	Loading…
01:41PM	Are SUPN, ITGR, ATKR, LNTH Obtaining Fair Deals for their Shareholders? (PR Newswire)
10:58AM	Lantheus Holdings to Be Acquired for Initial $6.7 Billion (The Wall Street Journal)
07:31AM	Curium Announces Definitive Agreement to Merge with Lantheus (GlobeNewswire)
Jul-27-26 06:51PM	LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value (Stocktwits)
Jul-23-26 08:30AM	Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time (GlobeNewswire)
Jun-26-26 04:01PM	Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide) (GlobeNewswire)
Jun-03-26 08:30AM	Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference (GlobeNewswire)
Jun-02-26 08:00AM	Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI's Image of the Year (GlobeNewswire)
May-27-26 08:30AM	Lantheus to Present at the William Blair 46th Annual Growth Stock Conference (GlobeNewswire)
May-22-26 04:36PM	Lantheus weighs potential $7 billion sale after Curium's offer, Bloomberg News reports (Reuters) +9.03%
08:30AM	Loading…
May-21-26 08:30AM	Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting (GlobeNewswire)
May-19-26 08:30AM	Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-07-26 07:26AM	Lantheus Holdings: Q1 Earnings Snapshot (Associated Press) +5.63%
07:00AM	Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
Apr-23-26 08:00AM	Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time (GlobeNewswire)
Mar-17-26 04:01PM	Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) (GlobeNewswire)
Mar-06-26 04:01PM	Lantheus Announces FDA Approval of PYLARIFY TruVu (piflufolastat F 18) Injection (GlobeNewswire) +10.27%
Mar-02-26 08:30AM	Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA (GlobeNewswire)
Feb-26-26 05:03PM	Lantheus Q4 Earnings Call Highlights (MarketBeat)
04:15PM	Lantheus Holdings Inc (LNTH) Q4 2025 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
07:19AM	Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations (StockStory)
07:18AM	Lantheus Holdings: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire)
Feb-24-26 10:08PM	Lantheus Earnings: What To Look For From LNTH (StockStory)
08:30AM	Lantheus to Present at March 2026 Investor Conferences (GlobeNewswire)
04:03AM	Loading…
Feb-18-26 04:03AM	TD Cowen Updates Financial Model Citing Upcoming Q4 Results for Lantheus Holdings, Inc. (LNTH) (Insider Monkey)
Feb-12-26 08:00AM	Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time (GlobeNewswire)
Jan-03-26 08:10AM	Lantheus closes SPECT business sale to SHINE Technologies (TipRanks)
Jan-02-26 08:00AM	Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies (GlobeNewswire)
Dec-21-25 10:31PM	Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3 (StockStory)
Dec-17-25 05:11PM	Truist Sees Upside in Lantheus Holdings, Inc. (LNTH) Despite PYLARIFY Pressure (Insider Monkey)
Dec-12-25 12:45PM	Why Lantheus (LNTH) Stock Is Up Today (StockStory) +5.58%
Dec-10-25 10:33AM	Wall Street Remains Bullish On Lantheus Holdings, Inc. (LNTH) (Insider Monkey)
Nov-24-25 08:30AM	Lantheus to Present Florbetaben F 18 Data at CTAD 2025 (GlobeNewswire)
Nov-16-25 11:01PM	Lantheus (LNTH): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Nov-13-25 12:36AM	5 Insightful Analyst Questions From Lantheus's Q3 Earnings Call (StockStory)
Nov-11-25 03:56PM	Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know (StockStory) +5.29%
Nov-07-25 12:31AM	LNTH Q3 Deep Dive: Leadership Transition and Product Diversification Shape Outlook (StockStory)
Nov-06-25 02:07PM	Lantheus Holdings Inc (LNTH) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Market ... (GuruFocus.com) -6.19%
07:43AM	Lantheus (NASDAQ:LNTH) Exceeds Q3 Expectations, Stock Soars (StockStory)
07:31AM	Lantheus Holdings: Q3 Earnings Snapshot (Associated Press Finance)
07:02AM	Lantheus Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
07:00AM	Lantheus Announces Leadership Transition Plan (GlobeNewswire)
Nov-04-25 10:12PM	Lantheus (LNTH) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
09:00AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights - LNTH (PR Newswire)
Nov-03-25 03:01AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
Oct-30-25 09:49AM	Investors Urged to Contact Levi & Korsinsky for Information Before November 10, 2025 - Lantheus Holdings, Inc. (LNTH) (Newsfile)
08:30AM	Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) (GlobeNewswire)
Oct-29-25 08:28AM	Here's Why Lantheus Holdings (LNTH) Fell in Q3 (Insider Monkey)
Oct-28-25 08:30AM	Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer's Disease (GlobeNewswire)
Oct-23-25 08:30AM	Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time (GlobeNewswire)
08:30AM	Investors Turn to AI-Driven Imaging Firms Targeting High-Growth Breast Cancer Market (PR Newswire)
Oct-21-25 03:12PM	Shareholders of Lantheus Holdings, Inc. (LNTH): Protect Your Rights Before November 10, 2025 - Contact Levi & Korsinsky (Newsfile)
Oct-17-25 08:45AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - LNTH (PR Newswire)
Oct-13-25 05:03PM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
09:28AM	Goldman Sachs Downgrades Lantheus (LNTH) PT to $77 Amid PYLARIFY Pricing Pressure, Slow Alzheimer's Drug Uptake (Insider Monkey)
Oct-10-25 09:29AM	Shareholders of Lantheus Holdings, Inc. (LNTH): Protect Your Rights Before November 10, 2025 - Contact Levi & Korsinsky (Newsfile)
Oct-07-25 07:46AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
Sep-30-25 06:06PM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH (PR Newswire)
Sep-26-25 09:00AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights - LNTH (PR Newswire)
Sep-24-25 12:05PM	Lantheus (LNTH) Stock Trades Up, Here Is Why (StockStory)
01:00AM	Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan (GlobeNewswire)
Sep-23-25 10:10AM	Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights LNTH (Business Wire)
Sep-19-25 06:33PM	Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information (PR Newswire)
Sep-15-25 11:31PM	Q2 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks (StockStory)
Sep-09-25 12:02AM	Lantheus (LNTH): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Sep-02-25 08:30AM	Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
04:05AM	FDA Accepts Lantheus Holdings, Inc. (LNTH)' NDA for New PSMA Imaging Agent (Insider Monkey)
Sep-01-25 12:38AM	2 Healthcare Stocks on Our Watchlist and 1 We Avoid (StockStory)
Aug-29-25 12:26AM	Leerink Partners Maintains a Buy on Lantheus Holdings (LNTH) With a $99 PT (Insider Monkey)
Aug-23-25 03:54AM	Lantheus Holdings, Inc. (LNTH) Announces FDA Approval of its New Drug Application for F 18 PSMA Imaging Agent (Insider Monkey)
Aug-13-25 12:16PM	Why Lantheus (LNTH) Stock Is Falling Today (StockStory)
01:34AM	5 Revealing Analyst Questions From Lantheus's Q2 Earnings Call (StockStory)
Aug-12-25 03:45PM	Why Lantheus (LNTH) Stock Is Falling Today (StockStory)
09:40AM	Starbucks upgraded, Shopify downgraded: Wall Street's top analyst calls (The Fly)
03:13AM	LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook (StockStory)
Aug-07-25 12:40PM	Lantheus Holdings (LNTH) Dives 28.6% on Tempered Growth Outlook (Insider Monkey) +5.76%
Aug-06-25 01:10PM	Why Lantheus (LNTH) Stock Is Falling Today (StockStory) -28.58%
07:55AM	Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8% (StockStory)
07:27AM	Lantheus Holdings: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
06:45AM	Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent (GlobeNewswire)
Aug-05-25 09:31AM	Lantheus Holdings Inc (LNTH) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-04-25 11:21PM	Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-28-25 11:11AM	Riley Reduces Lantheus Holdings (LNTH) PT to $109, Maintains Buy Rating (Insider Monkey)
Jul-27-25 10:01AM	Lantheus Holdings Expands Alzheimer's Diagnostics Despite Recent Stock Dip (Insider Monkey)
Jul-23-25 08:00AM	Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time (GlobeNewswire)
Jul-22-25 07:00AM	Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D (GlobeNewswire)
Jul-18-25 12:05AM	Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-16-25 12:10PM	Why Lantheus (LNTH) Stock Is Down Today (StockStory) -8.43%
Jul-11-25 03:30PM	Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know (StockStory)
Jul-03-25 12:34AM	1 Healthcare Stock to Target This Week and 2 to Be Wary Of (StockStory)
Jul-02-25 01:35AM	Lantheus's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-29-25 09:56PM	Riley Maintains 'Buy' Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT (Insider Monkey)
Jun-28-25 04:16AM	Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment (Insider Monkey)

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

CEO & Executive ChairpersonMs. Mary Anne Heino

CFAMr. Robert J. Marshall Jr.

Chief Administrative OfficerMr. Daniel M. Niedzwiecki

Chief Commercial OfficerMs. Amanda M. Morgan

Head of Research & DevelopmentDr. Ludger Dinkelborg Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Blanchfield Paul	Former Officer	Feb 02 '26	Proposed Sale	66.97	6,713	449,570	Feb 02 01:32 PM
Blanchfield Paul	Former Officer	Jan 06 '26	Proposed Sale	69.53	7,217	501,798	Jan 06 11:43 AM
Blanchfield Paul	Officer	Dec 12 '25	Proposed Sale	66.82	3,265	218,151	Dec 12 03:16 PM
Blanchfield Paul	Former Officer	Nov 26 '25	Proposed Sale	58.31	11,776	686,665	Nov 26 10:43 AM
Blanchfield Paul	Former Officer	Nov 14 '25	Proposed Sale	52.70	16,530	871,106	Nov 14 02:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LNTH

Lantheus Holdings Inc

Upgrade your Finviz experience